Drug tests can analyze urine, oral fluid, hair, blood, breath, sweat, nails, and other specimens. Each method answers a somewhat different question. The best choice depends on the reason for testing, how recently exposure matters, collection conditions, available laboratory methods, governing rules, and the consequences of the result.
This guide compares the major methods and links to detailed explanations. For the complete subject, return to Drug Testing: The Complete Guide.
Quick comparison of common methods
| Method | Common strengths | Important limitations | Typical uses |
|---|---|---|---|
| Urine | Established procedures; broad availability; many validated panels | Usually does not establish impairment; collection and dilution issues require controls | Workplace, court, treatment, clinical monitoring |
| Oral fluid | Directly observed collection; often emphasizes more recent exposure | Lower specimen volume; food, collection conditions, and device requirements can matter | Workplace, roadside or safety programs where authorized, clinical testing |
| Hair | Longer retrospective view; difficult to substitute at collection | Less useful for very recent use; cosmetic treatment, growth, sample site, and contamination require careful interpretation | Longer-term pattern assessment in non-federal programs |
| Blood | Measures drug or metabolite in circulation; useful in clinical and forensic contexts | Invasive; shorter detection for many drugs; concentration does not always map cleanly to impairment | Emergency care, forensic investigations, selected clinical questions |
| Breath | Noninvasive; established relationship to alcohol testing in regulated programs | Most established for alcohol rather than broad drug panels | Alcohol screening and confirmation |
Urine drug testing
Urine is one of the most widely used specimens. Tests often look for metabolites excreted after the body processes a substance. For many drugs, urine can remain positive after the period in which the parent drug would be measurable in blood or oral fluid. That makes urine useful for detecting prior exposure but generally unsuitable for deciding whether someone is impaired at the moment of collection.
Well-designed urine programs address identity, privacy, temperature when applicable, specimen seals, chain of custody, validity testing, screening, confirmation, and medical review. Federal agency collections generally use a split specimen. A dilute, invalid, adulterated, or substituted classification has a technical definition within the governing program and should not be inferred from appearance alone.
Read the complete Urine Drug Testing guide.
Saliva or oral-fluid testing
Oral fluid is collected from the mouth with an authorized collection device. Because collection can be directly observed without the privacy concerns of an observed urine collection, it can reduce certain collection risks. For many drugs, oral fluid tends to emphasize a more recent period of exposure than urine or hair, although the actual detection window depends on the drug, device, laboratory method, cutoff, and individual factors.
“Saliva test” is a common phrase, but regulated programs often use the more precise term “oral fluid.” HHS authorizes oral fluid as well as urine for federal workplace drug testing, subject to the applicable Mandatory Guidelines, authorized panels, certified facilities, and collection procedures.
Read the complete Saliva Drug Testing guide.
Hair drug testing
Hair testing can offer a longer retrospective view than urine, blood, or oral fluid. A laboratory typically analyzes a segment cut close to the scalp, although body hair may be used under some policies. The length and source of the sample affect the period represented.
Hair does not provide a precise calendar of use. Incorporation varies by substance, hair growth, cosmetic treatment, and analytical method. Laboratories must also address external contamination and washing procedures. Hair testing is not currently an authorized specimen for federal agency workplace programs under the HHS Mandatory Guidelines.
Read the complete Hair Drug Testing guide.
Blood drug testing
Blood testing can identify drugs or metabolites circulating at the time the sample is collected. It may be ordered in emergency medicine, toxicology, impaired-driving investigations, postmortem examinations, or other settings where timing and concentration are relevant.
Interpretation can be complex. Drug concentrations may rise and fall rapidly, and the relationship between a measured concentration and functional impairment varies among substances and people. Blood collection is invasive, requires trained personnel, and follows medical or forensic handling requirements.
Read the complete Blood Drug Testing guide.
At-home tests and point-of-care devices
At-home and point-of-care tests usually provide a rapid qualitative screen. They may be useful when their label matches the intended specimen and drug panel, the product is stored correctly, instructions are followed, and results are read within the specified time.
A preliminary positive should not be treated as a final answer in a high-consequence decision. The FDA recommends laboratory confirmation of preliminary positive home-test results. A negative result also has limits: the drug may not be included, the specimen may have been collected outside the detection period, the concentration may be below the cutoff, or the product may have been used incorrectly.
Compare At-Home and Laboratory Drug Tests.
How to choose a testing method
Start with the question the test must answer. A program interested in relatively recent exposure may choose differently from one evaluating a longer historical pattern. A federally regulated employer may have far less discretion than a private individual purchasing a home test.
- Define the purpose. Workplace compliance, clinical care, court monitoring, and personal screening require different safeguards.
- Identify governing rules. Confirm which specimens and laboratories are permitted.
- Specify the panel and analytes. A method cannot detect a substance that was not included.
- Consider the relevant period. Avoid presenting any specimen as an exact clock.
- Plan confirmation and review. Decide how non-negative screens, prescriptions, and disputed results will be handled.
- Protect privacy and chain of custody. The required process depends on the consequences of the test.
Use the How to Choose a Drug-Test Type decision guide for a structured comparison.
Related guides
- Drug Detection Windows
- Screening Versus Confirmation
- The Collection Process
- Drug-Test Method Comparison Chart
Sources
- SAMHSA: Workplace Drug Testing Resources
- SAMHSA: Federal Workplace Drug Testing FAQs
- FDA: Drugs of Abuse Home Use Test
- MedlinePlus: Drug Testing
Last evidence review: October 29, 2026.